TABLE 2.
Predictors of COVID-19 Seropositivity Among Patients With Schizophrenia
| B | SE | Wald | df | Sig. | Exp(B) | 95% CI for Exp(B) | ||
|---|---|---|---|---|---|---|---|---|
| Lower | Upper | |||||||
| Type of antipsychotic | ||||||||
| FGA use (reference category) | 1.428 | 2 | 0.490 | |||||
| SGA use | 0.262 | 0.528 | 0.246 | 1 | 0.620 | 1.299 | 0.462 | 3.657 |
| Combined (FGA + SGA) use | 0.353 | 0.375 | 0.883 | 1 | 0.347 | 1.423 | 0.682 | 2.970 |
| Sex | −0.365 | 0.405 | 0.812 | 1 | 0.368 | 0.695 | 0.314 | 1.535 |
| BMI | 0.048 | 0.103 | 0.213 | 1 | 0.644 | 1.049 | 0.856 | 1.285 |
| Age | −0.040 | 0.017 | 5.542 | 1 | 0.019 | 0.961 | 0.929 | 0.993 |
| Comorbidity index | 0.824 | 0.192 | 18.492 | 1 | 0.000a | 2.280 | 1.566 | 3.320 |
| CPZE dose of AP | 0.005 | 0.001 | 45.663 | 1 | 0.000a | 1.005 | 1.004 | 1.007 |
| Place of residence | 0.547 | 0.302 | 3.279 | 1 | 0.070 | 1.728 | 0.956 | 3.125 |
| Marriage status | 2.173 | 0.568 | 14.617 | 1 | 0.000a | 1.114 | 1.037 | 1.347 |
| Smoking | −1.206 | 0.321 | 14.108 | 1 | 0.000a | 0.299 | 0.160 | 0.562 |
| No. psychiatric hospitalizations | 0.149 | 0.086 | 2.995 | 1 | 0.084 | 1.161 | 0.980 | 1.375 |
| No. psychiatric outpatient admissions | 0.189 | 0.083 | 5.198 | 1 | 0.023 | 1.209 | 1.027 | 1.422 |
| Duration of psychiatric disease | −0.003 | 0.056 | 0.003 | 1 | 0.955 | 0.997 | 0.894 | 1.112 |
aSignificant after Bonferroni correction (p < 0.00416).